Followers | 840 |
Posts | 120583 |
Boards Moderated | 14 |
Alias Born | 09/05/2002 |
Thursday, February 24, 2011 10:33:26 PM
[Updated for SEC filings through 2/24/11.]
The table entries below include both ordinary and restricted
shares and both vested and non-vested options.
*10b5-1 selling plan in effect.
Shares Options
Officers
*Craig Wheeler (CEO) 402,735 775,000
*G Venkataraman (SVP/R&D) 367,680 182,820
*John Bishop (SVP/Pharma) 55,362 142,359
*Richard Shea (CFO) 47,076 272,378
*Bruce Leicher (Gen Cnsl) 46,930 160,228
*James Roach (CMO) 26,158 228,428
Directors
John Clarke 77,123 126,000
Bruce Downey 0 45,000
Marsha Fanucci 0 126,000
Peter Hutt 67,863 131,000
*Bennett Shapiro 7,000 138,450
*Elizabeth Stoner 4,160 66,700
James Sulat 7,000 53,000
======================== ========= =========
All thirteen insiders 1,109,087 2,447,363
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM
Future Hospitality Ventures Unveils Bold, New AI-Driven Initiative to Revolutionize the $300 Billion Hospitality Market • NGTF • Oct 16, 2024 7:07 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM